Surmodics Market Cap

Surmodics has a market cap or net worth of $371.13 million as of April 24, 2024. Its market cap has increased by 13.81% in one year.

Market Cap

371.13M

Enterprise Value

365.40M

1-Year Change

13.81%

Ranking

#3180

Market Cap Chart

Since December 1, 1998, Surmodics's market cap has increased from $67.50M to $371.13M, an increase of 449.83%. That is a compound annual growth rate of 6.94%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2024	371.10M	-3.16%
Apr 23, 2024	383.20M	6.00%
Apr 22, 2024	361.50M	-4.14%
Apr 19, 2024	377.10M	0.37%
Apr 18, 2024	375.70M	-0.48%
Apr 17, 2024	377.50M	-0.32%
Apr 16, 2024	378.70M	0.69%
Apr 15, 2024	376.10M	-2.16%
Apr 12, 2024	384.40M	-2.46%
Apr 11, 2024	394.10M	0.15%
Apr 10, 2024	393.50M	-0.38%
Apr 9, 2024	395.00M	0.95%
Apr 8, 2024	391.30M	1.50%
Apr 5, 2024	385.50M	-0.36%
Apr 4, 2024	386.90M	0.81%
Apr 3, 2024	383.80M	-0.03%
Apr 2, 2024	383.90M	-3.35%
Apr 1, 2024	397.20M	-4.91%
Mar 28, 2024	417.70M	1.88%
Mar 27, 2024	410.00M	2.09%
Mar 26, 2024	401.60M	2.82%
Mar 25, 2024	390.60M	-0.81%
Mar 22, 2024	393.80M	-2.11%
Mar 21, 2024	402.30M	-1.95%
Mar 20, 2024	410.30M	3.72%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Mereo BioPharma Group	389.36M
Biomea Fusion	388.70M
Mersana Therapeutics	387.07M
Tourmaline Bio	387.01M
Aquestive Therapeutics	385.06M
Revance Therapeutics	381.43M
PepGen	379.60M
Pulse Biosciences	378.85M

Market Cap Rankings